aclidinium vs tezepelumab
Side-by-side comparison of aclidinium and tezepelumab Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tudorza Pressair
Tezspire
Duaklir Pressair is a combination medicine used to help people with COPD breathe better. It contains two medicines that open up the airways in your lungs.
Tezspire is a medicine that can help control severe asthma and chronic rhinosinusitis with nasal polyps. It works by blocking a substance in your body that causes inflammation.
Duaklir Pressair is used to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open the airways and make it easier to breathe for people with COPD.
Tezspire is used to treat severe asthma in adults and children 12 years and older. It's also used for chronic rhinosinusitis with nasal polyps (CRSwNP) that is not well controlled. Tezspire helps to reduce inflammation in your airways and sinuses, making it easier to breathe.
Duaklir Pressair contains two medicines that work in different ways. One medicine relaxes the muscles around your airways, opening them up. The other medicine prevents the muscles from tightening.
Tezspire is a special type of antibody that blocks a protein called TSLP. TSLP causes inflammation in the airways and sinuses. By blocking TSLP, Tezspire helps to reduce swelling and mucus production.
- • Upper respiratory infection
- • Headache
- • Back pain
- • Sore throat
- • Joint pain
- • Back pain
- • Runny nose
- • Upper respiratory infection
- Difficulty breathing 1,869
- Inhaler not working correctly 1,281
- Skipped a dose of medicine 1,017
- Asthma 814
- Chronic obstructive pulmonary disease (COPD) 764
No adverse event reports.
LABAs, such as formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, increase the risk of asthma-related death. Duaklir Pressair is not for asthma. Do not use Duaklir Pressair if you are allergic to milk proteins or any of the ingredients in it. Tell your doctor if you have heart problems, glaucoma, trouble urinating, diabetes, or seizures.
If you have a parasitic infection, it should be treated before you start using Tezspire. Avoid live vaccines while using Tezspire. Do not stop taking steroid medicines suddenly when you start Tezspire. Talk to your doctor about how to slowly lower your steroid dose if needed.
It is not known if Duaklir Pressair will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if this medicine passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking Duaklir Pressair.
It is not known if Tezspire will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Tezspire passes into breast milk. Talk to your doctor about the best way to feed your baby if you are using Tezspire.
Also Compare — Nearby Drugs
Compare aclidinium with
How to Read This aclidinium vs tezepelumab Comparison
aclidinium is classified in the Long-Acting Muscarinic Antagonist (LAMA) drug class, while tezepelumab sits within the Anti-TSLP Monoclonal Antibody class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aclidinium has 5,745 submissions while tezepelumab has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aclidinium and tezepelumab — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.